Figure 7.
Figure 7. Increased transduction in NOD/SCID mice suggests a role for innate immunity in viral clearance. SCID and NOD/SCID mice (n = 5 per group) with or without IVIG treatment received intravenous injections of 5 × 1011 vg/mouse AAV2-hFIX. FIX levels were measured at 4 weeks after vector injection.

Increased transduction in NOD/SCID mice suggests a role for innate immunity in viral clearance. SCID and NOD/SCID mice (n = 5 per group) with or without IVIG treatment received intravenous injections of 5 × 1011 vg/mouse AAV2-hFIX. FIX levels were measured at 4 weeks after vector injection.

Close Modal

or Create an Account

Close Modal
Close Modal